SCHEMBL8286362

SCHEMBL8286362

Cc1cc(SCC2CCCCC2)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 2/20 0.43
PDE11A Q9HCR9 1/20 0.42
KDM1A O60341 1/20 0.41
METAP2 P50579 3/20 0.37
ABCB1 P08183 1/20 0.36
CDK4 P11802 3/20 0.35
CCND1 P24385 3/20 0.35
CCND2 P30279 3/20 0.35
CCND3 P30281 3/20 0.35
DRD1 P21728 2/20 0.35
DRD5 P21918 2/20 0.35
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPK1 P28482 2/20 0.33
POLB P06746 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287563 0.85 PDE7A (0.43) PDE7APDE11AKDM1AMETAP2ABCB1
SCHEMBL8286368 0.83 PDE11A (0.44) PDE11AKDM1AABCB1KDM4EALDH1A1
SCHEMBL8361765 0.82 GAA (0.45) PDE11AKDM4EALDH1A1MAPK1POLB
SCHEMBL8285251 0.81 PDE11A (0.48) PDE11ACDK4CCND1CCND2CCND3
SCHEMBL8286358 0.81 USP2 (0.46) PDE11AKDM4EMEN1USP2ALDH1A1
SCHEMBL8287463 0.80 SMN1; SMN2 (0.48) KDM4EUSP2ALDH1A1HTTKMT2A
SCHEMBL8286365 0.80 PDE11A (0.46) PDE11ACDK4CCND1CCND2CCND3
SCHEMBL8285198 0.78 PDE11A (0.45) PDE11ACDK4CCND1KDM4EMEN1
SCHEMBL8286357 0.78 ALDH1A1 (0.43) PDE11AKDM4EMEN1USP2ALDH1A1
SCHEMBL8286356 0.78 CYP3A4 (0.41) PDE11AKDM4EUSP2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed